Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Atlas Arteria ( (AU:ALX) ).
Atlas Arteria has reported the cessation of 20,584 performance rights under its ALXAL security code after the rights lapsed on 31 March 2026. The lapse occurred because the conditions attached to these conditional rights were not met or became incapable of being satisfied, marginally reducing the company’s pool of potential equity issuance and reflecting non‑achievement of specific performance hurdles within its incentive arrangements.
The most recent analyst rating on (AU:ALX) stock is a Hold with a A$4.96 price target. To see the full list of analyst forecasts on Atlas Arteria stock, see the AU:ALX Stock Forecast page.
More about Atlas Arteria
Atlas Arteria is a listed infrastructure company focused on owning and operating toll roads and related transport assets. Through its corporate structure, including Atlas Arteria Limited and Atlas Arteria International Limited, the group provides investors exposure to long‑term, income‑generating road infrastructure in key global markets.
YTD Price Performance: -8.45%
Average Trading Volume: 2,426,764
Technical Sentiment Signal: Sell
Current Market Cap: A$6.2B
Find detailed analytics on ALX stock on TipRanks’ Stock Analysis page.